Teva Continues to Invigorate Injectable Portfolio with the Launch of Argatroban Injection in the United States
Amgen Announces FDA Advisory Committee Meeting To Review RepathaTM (Evolocumab) As A Treatment For High Cholesterol
LAKE FOREST, Ill., April 28, 2015 /PRNewswire/ -- Hospira, Inc.
Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed
Clinical Studies Have Shown Stopping Medication Early Puts Patients at a Greater Risk of Another Heart Event and Death
BOTHELL, Wash. and VANCOUVER, British Columbia, April 27, 2015 /PRNewswire/
Board concludes that approach grossly undervalues Mylan, includes low-quality, high-risk Teva stock, and would expose Mylan to a problematic culture and leadership with poor record of delivering s
China Jo-Jo Drugstore Signed a New Sales Incentive Agreement with Wyeth Pharmaceutical, a Subsidiary of Pfizer
HANGZHOU, China, April 27, 2015 /PRNewswire/ -- China Jo-Jo Drugstores, Inc.
Novartis announces Phase III study of Arzerra(R) met primary endpoint of improved progression-free survival in patients with relapsed CLL
NEW BRUNSWICK, N.J., April 20, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a review
CYRAMZA Now Approved in the U.S.